Copyright
©The Author(s) 2024.
World J Stem Cells. Dec 26, 2024; 16(12): 1012-1021
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1012
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1012
Figure 2 Monthly change of estimated glomerular filtration rate at pretreatment and 6 months after cell therapy.
Delta estimated glomerular filtration rate/month improved from negative to positive values in case 2, 3, and 4 after cell therapy. Delta estimated glomerular filtration rate/month in case 1 slightly improved. However, it was still negative value. eGFR: Estimated glomerular filtration rate.
- Citation: Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial. World J Stem Cells 2024; 16(12): 1012-1021
- URL: https://www.wjgnet.com/1948-0210/full/v16/i12/1012.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i12.1012